Literature DB >> 3027198

The pathogenesis of acute viral encephalitis and postinfectious encephalomyelitis.

R T Johnson.   

Abstract

Japanese encephalitis and postmeasles encephalomyelitis represent two important forms of acute encephalitis in the developing world. Japanese encephalitis accounts for 20,000 acute illnesses per year, and measles encephalomyelitis accounts for as many as 100,000. Both are accompanied by mortalities of 20%-30%, and in both forms, approximately one-half of the survivors have neurological sequelae. Therefore, these two diseases are responsible for a considerable proportion of worldwide mental and motor disabilities. Furthermore, both diseases are preventable with use of safe vaccines. Despite these similarities, their very different pathologies appear to be based on different mechanisms of pathogenesis (table 2). In Japanese encephalitis there is direct invasion of the virus into the nervous system, selective infection and destruction of neurons, and evidence that both humoral and cellular immune responses attenuate the infection. In measles encephalomyelitis there is little evidence that the virus invades the nervous system. Rather, measles virus infects lymphoid cells and causes abnormalities in immune regulation. Humoral immune responses are not found within the nervous system, and the cellular immune response may be inappropriately directed against host antigens. In measles encephalomyelitis, the inflammatory cells entering the nervous system may be the effector cells of autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3027198     DOI: 10.1093/infdis/155.3.359

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  30 in total

Review 1.  Acute disseminated encephalomyelitis.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  2003-01       Impact factor: 2.401

Review 2.  Admission to neurological intensive care: who, when, and why?

Authors:  Robin S Howard; Dimitri M Kullmann; Nicholas P Hirsch
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

3.  Measles virus-induced immune suppression in the cotton rat (Sigmodon hispidus) model depends on viral glycoproteins.

Authors:  S Niewiesk; I Eisenhuth; A Fooks; J C Clegg; J J Schnorr; S Schneider-Schaulies; V ter Meulen
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 4.  [Acute disseminated encephalomyelitis].

Authors:  M Politi; P Papanagiotou; I Q Grunwald; C Roth; W Reith
Journal:  Radiologe       Date:  2008-06       Impact factor: 0.635

5.  Epstein-Barr virus encephalitis presenting as cerebellar hemorrhage.

Authors:  Shyam Sabat; Amit Agarwal; Thomas Zacharia; Samuel Labib; Jacob Yousef
Journal:  Neuroradiol J       Date:  2015-10-16

6.  Nipah viral encephalitis or Japanese encephalitis? MR findings in a new zoonotic disease.

Authors:  C C Lim; Y Y Sitoh; F Hui; K E Lee; B S Ang; E Lim; W E Lim; H M Oh; P A Tambyah; J S Wong; C B Tan; T S Chee
Journal:  AJNR Am J Neuroradiol       Date:  2000-03       Impact factor: 3.825

7.  Serial cerebral CT abnormalities in relapsing acute disseminated encephalomyelitis.

Authors:  R W Walker; J Gawler
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-09       Impact factor: 10.154

8.  Extensive acute disseminated encephalomyelitis in a young girl responding to intravenous methylprednisolone.

Authors:  Rajesh Verma; Tushar B Patil; Rakesh Lalla; Manoj Kumar
Journal:  BMJ Case Rep       Date:  2013-10-03

9.  Measles virus-induced changes in leukocyte function antigen 1 expression and leukocyte aggregation: possible role in measles virus pathogenesis.

Authors:  N Attibele; P R Wyde; J Trial; S C Smole; C W Smith; R D Rossen
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

10.  Susceptibility to measles virus-induced encephalitis in mice correlates with impaired antigen presentation to cytotoxic T lymphocytes.

Authors:  S Niewiesk; U Brinckmann; B Bankamp; S Sirak; U G Liebert; V ter Meulen
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.